Stay updated on Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial
Sign up to get notified when there's something new on the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page.

Latest updates to the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, indicating a site software/footer update rather than a change to the underlying study record.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Contacts/Locations and Study Status sections on 2026-03-24. A version from 2025-09-02 was deleted.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a new revision entry for v3.4.3 and removed the v3.4.2 entry in the record history. This update reflects metadata changes to the history log rather than substantive trial data.SummaryDifference0.1%

- Check83 days agoChange DetectedMinor revision history updates were made: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo/Quizartinib vs Chemo/Placebo in FLT3-wt AML Clinical Trial page.